Biotech · Public company · Baltimore, MD, US
NextCure, Inc.
Ticker NXTC · SEC CIK 0001661059
Track this companyFree. Adds NextCure, Inc. to your Dealase workspace and tells you when its record changes.
Clinical trials83 recruiting or active
Pipeline programs6From trials and the company's site
Disclosed deals0None found yet
Cash runwayNot availableNo recent cash burn filed
Pipeline6
- NC318Phase 2 · Advanced or Metastatic Solid TumorsClinicalTrials.gov · fetched Nov 12, 2026
- NC410Phase 2 · Advanced or Metastatic Solid TumorsClinicalTrials.gov · fetched Nov 12, 2026
- NC762Phase 2 · Advanced or Metastatic Solid TumorsClinicalTrials.gov · fetched Nov 12, 2026
- pembrolizumabPhase 2 · Advanced or Metastatic Solid TumorsClinicalTrials.gov · fetched Nov 12, 2026
- NC525Phase 1 · Relapsed or Refractory Acute Myeloid LeukemiaClinicalTrials.gov · fetched Nov 12, 2026
- SIM0505 for injectionPhase 1 · Advanced Solid TumorsClinicalTrials.gov · fetched Nov 12, 2026
Clinical trials8
- NC410 and FOLFIRINOX in Combination With Nivolumab With or Without Ipilimumab in Patients With Untreated Metastatic Pancreatic CancerPHASE2 · RECRUITING · started Sep 4, 2025ClinicalTrials.gov NCT06941857 · fetched Nov 12, 2026
- A Phase I Study of SIM0505 in Participants With Advanced Solid TumorsPHASE1 · RECRUITING · started Feb 26, 2025ClinicalTrials.gov NCT06792552 · fetched Nov 12, 2026
- A Safety, Tolerability and Efficacy Study of NC525 in Subjects With Advanced Myeloid NeoplasmsPHASE1 · TERMINATED · started Feb 28, 2023ClinicalTrials.gov NCT05787496 · fetched Nov 12, 2026
- A Safety, Tolerability and Efficacy Study of NC410 Plus Pembrolizumab in Participants With Advanced Unresectable or Metastatic Solid TumorsPHASE1_PHASE2 · TERMINATED · started Oct 6, 2022ClinicalTrials.gov NCT05572684 · fetched Nov 12, 2026
- A Safety and Tolerability Study of NC762 in Subjects With Advanced or Metastatic Solid TumorsPHASE1_PHASE2 · TERMINATED · started Jun 30, 2021ClinicalTrials.gov NCT04875806 · fetched Nov 12, 2026
- The Study of NC318 Alone or in Combination With Pembrolizumab in Patients With Advanced Non-small Cell Lung CancerPHASE2 · ACTIVE_NOT_RECRUITING · started Feb 4, 2021ClinicalTrials.gov NCT04699123 · fetched Nov 12, 2026
- A Safety and Tolerability Study of NC410 in Subjects With Advanced or Metastatic Solid TumorsPHASE1_PHASE2 · TERMINATED · started Jun 10, 2020ClinicalTrials.gov NCT04408599 · fetched Nov 12, 2026
- A Safety and Tolerability Study of NC318 in Subjects With Advanced or Metastatic Solid TumorsPHASE1_PHASE2 · COMPLETED · started Oct 1, 2018ClinicalTrials.gov NCT03665285 · fetched Nov 12, 2026
SEC filings12
- 10-Q · 10-QSEC EDGAR · filed Nov 10, 2026 · fetched Nov 12, 2026
- 8-K · 8-KSEC EDGAR · filed Nov 10, 2026 · fetched Nov 12, 2026
- 8-K · 8-KSEC EDGAR · filed Oct 30, 2026 · fetched Nov 12, 2026
- 8-K · 8-KSEC EDGAR · filed Sep 25, 2026 · fetched Nov 12, 2026
- 8-K · 8-KSEC EDGAR · filed Sep 3, 2026 · fetched Nov 12, 2026
- 10-Q · 10-QSEC EDGAR · filed Aug 6, 2026 · fetched Nov 12, 2026
- 8-K · 8-KSEC EDGAR · filed Aug 6, 2026 · fetched Nov 12, 2026
- 8-K · FORM 8-KSEC EDGAR · filed Jul 14, 2026 · fetched Nov 12, 2026
- 8-K · 8-KSEC EDGAR · filed Jun 25, 2026 · fetched Nov 12, 2026
- 8-K · 8-KSEC EDGAR · filed Jun 1, 2026 · fetched Nov 12, 2026
- 10-Q · 10-QSEC EDGAR · filed May 7, 2026 · fetched Nov 12, 2026
- 8-K · 8-KSEC EDGAR · filed May 7, 2026 · fetched Nov 12, 2026